We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Review · October 09, 2019

Diagnosis and Management of Rare Dyslipidemias

The Lancet Diabetes & Endocrinology


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Diabetes & Endocrinology
Rare Dyslipidaemias, From Phenotype to Genotype to Management: A European Atherosclerosis Society Task Force Consensus Statement
Lancet Diabetes Endocrinol 2019 Sep 30;[EPub Ahead of Print], RA Hegele, J Borén, HN Ginsberg, M Arca, M Averna, CJ Binder, L Calabresi, MJ Chapman, M Cuchel, A von Eckardstein, R Frikke-Schmidt, D Gaudet, GK Hovingh, F Kronenberg, D Lütjohann, KG Parhofer, FJ Raal, KK Ray, AT Remaley, JK Stock, ES Stroes, L Tokgözoğlu, AL Catapano

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading